The importance of lowering cholesterol in patients with coronary heart disease

Area of Science:

• Cardiology
• Preventive Medicine
• Lipid Metabolism

Background:

• Cardiovascular disease (CVD) is a leading cause of mortality.
• Patients with existing CVD account for a substantial proportion of myocardial infarctions and coronary disease deaths.
• Elevated cholesterol levels are a major risk factor for CVD.

Purpose of the Study:

• To evaluate the benefits of cholesterol-lowering therapies in patients with coronary disease.
• To determine the importance of achieving specific low-density lipoprotein (LDL) cholesterol targets.
• To support lipid management strategies for secondary and primary prevention of atherosclerotic vascular disease.

Main Methods:

• Review of recent clinical trials on cholesterol-lowering interventions.
• Analysis of cardiovascular morbidity and mortality data in relation to cholesterol levels.
• Assessment of the impact of LDL cholesterol targets on disease prevention.

Main Results:

• Cholesterol lowering provides significant benefits in reducing cardiovascular morbidity and mortality.
• These benefits extend to patients with average cholesterol levels.
• A target low-density lipoprotein cholesterol level of <= 100 mg/dl is supported by clinical evidence.

Conclusions:

• Attaining and maintaining optimal lipid targets is essential for secondary prevention in patients with existing CVD.
• Optimal lipid management also plays a vital role in the primary prevention of atherosclerotic vascular disease.
• Evidence supports aggressive lipid management to reduce cardiovascular risk in at-risk populations.